Shop

Showing the single result

COVID-19 nanoMIPs for sensors
MIP Discovery’s ultra-high sensitivity COVID-19 nanoMIPs have been designed to detect the SARS-CoV-2 virus in rapid point of care devices.
Find out more
Select options

Performance Data

Analytical sensitivity

of <5 ng/ml in a sensor

Analytical sensitivity has been demonstrated to <5 fg/ml for the RBD spike protein in a thermal resistance sensor device.

Selectivity to SARS-CoV-2

spike protein

The SARS-CoV-2 nanoMIP has been shown to only detect SARS-CoV-2 spike Glycoprotein and not detect Human Coronavirus 299E Spike Glycoprotein, Human Coronavirus HKU1 Spike Glycoprotein and Human Coronavirus OC43 Spike Glycoprotein in Dot Blot

Excellent batch to batch

consistency

The chemical manufacturing process employed ensures batch to batch consistency and reproducibility of the SARS-CoV-2 nanoMIP.

Research use only